Molecular Imaging: Page 27

MITA asks CMS to improve radiopharmaceutical coverage

By AuntMinnie.com staff writers

The Medical Imaging and Technology Alliance (MITA) has raised concerns over a proposed 2024 Medicare rule.

September 13, 2023

New PET tracer shows promise visualizing cardiac amyloidosis

By Will Morton

A team at Harvard University in Cambridge, MA, has tested the first PET radiotracer specifically for visualizing cardiac amyloidosis, also known as "stiff heart syndrome," according to a recent study.

September 12, 2023

Dual-targeting PET tracer begins to show its stripes

By Will Morton

New evidence suggests that PET/CT imaging with a gallium-68 (Ga-68)-labeled heterodimeric radiotracer is highly effective for visualizing various types of malignant cancer, according to a group in China.

September 12, 2023

Kromek highlights Spectrum's integration of its detectors

By AuntMinnie.com staff writers

Radiation technology developer Kromek Group is highlighting that Spectrum Dynamics Medical has introduced Veriton-CT 300, which incorporated Kromek's digital detectors.

September 11, 2023

PET imaging predicts long-term outcomes in Parkinson's disease

By Will Morton

PET brain imaging in individuals with early Parkinson's disease can show which patients are at higher risk of long-term effects, according to a study by researchers in Italy.

September 11, 2023

FAPI-PET/CT may improve treatment of cancer patients

By Will Morton

Gallium-68 (Ga-68) FAPI-PET/CT imaging -- a highly accurate experimental approach for detecting cancer -- may further improve outcomes for patients undergoing radiation therapy, according to a recent analysis by German researchers.

September 11, 2023

FDA clears Xeos Aura 10 PET-CT specimen imaging system

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has approved Xeos' Aura 10 PET-CT specimen imaging system for the operating room.

September 10, 2023

Eczacıbaşı-Monrol to expand Lu-177 production

By AuntMinnie.com staff writers

Turkish radiopharmaceutical company Eczacıbaşı-Monrol plans to expand its Lutetium-177 (Lu-177) production capacity.

September 10, 2023

PET/CT-based model predicts prostate cancer in the 'PSA grey zone'

By Will Morton

Combining PET/CT with traditional clinical risk factors can detect prostate cancer in cases considered borderline based on prostate-specific antigen (PSA) levels -- in other words, cases in the "PSA grey zone," according to a group in Hunan, China.

September 10, 2023

PET reveals link between heart health and brain metabolism

By Will Morton

A PET study suggests that maintaining cardiovascular health during midlife can help reduce the risk of neurodegenerative disease later in life, according to a group in Spain.

September 6, 2023

Telix touts studies at EANM 2023

By AuntMinnie.com staff writers

Telix Pharmaceuticals is highlighting studies set to be presented at the European Association of Nuclear Medicine meeting to be held September 9-13 in Vienna.

September 5, 2023

FDOPA-PET/CT predicts survival in patients with midgut NETs

By Will Morton

PET/CT imaging with F-18 fluorodopa (FDOPA) is an effective approach for detecting neuroendocrine tumors (NETs) -- and now the scans may be used to predict survival in patients with tumors in the midgut, according to researchers in France.

September 5, 2023

Previous Page

Page 27 of 612

Next Page